LIFE Message Board Post 9269460 | aTyr Pharma Inc.
home / stock / life / life message board
mark127
(investorshub)
Posted on: Sep/14/2021 12:25:54
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165899471
11.55
News, Short Squeeze, Breakout and More Instantly...
-
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment in the second quarter of 2024. Ended the first quarter 2024 with $87.7 million in cash, cash equivalents, restricted cash and investments. SAN DIEGO, May 02, 2024 (GLOBE NEWS...
-
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (NASDAQ:LIFE), a clinical stage biotechnology company engaged in the discovery a...
-
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcom...